Orbital decompression in Graves’ ophthalmopathy associated with pretibial myxedema

Vahab Fatourechi, J. A. Garrity, G. B. Bartley, E. J. Bergstralh, C. A. Gorman

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Pretibial myxedema (thyroid dermopathy), an uncommon autoimmune manifestation of Graves’ disease, is almost always associated with significant ophthalmopathy and may be a marker for an unusually prolonged or different course for the ophthalmopathy. However, it is not known if the response to therapy for eye disease is different in patients with pretibial myxedema. We compared the results of orbital decompression in 385 patients without and 52 patients with pretibial myxedema operated on between 1969 and 1989. Preoperative and postoperative characteristics of severe Graves’ ophthalmopathy did not differ in patients with or without pretibial myxedema except for slightly, but not significantly, more proptosis and diplopia in the pretibial myxedema group. In response to a 1989–1990 questionnaire (83% response rate, n=364), 89.1% without (n=319) and 88.9% with (n=45) pretibial myxedema reported satisfactory or acceptable appearance of the eyes. Self-assessment of visual acuity, eye comfort, diplopia, and overall rate of satisfaction with the status of the eyes did not differ between the groups. The presence of pretibial myxedema does not herald an unsatisfactory response to transantral orbital decompression.

Original languageEnglish (US)
Pages (from-to)433-437
Number of pages5
JournalJournal of endocrinological investigation
Volume16
Issue number6
DOIs
StatePublished - Jan 1 1993

Fingerprint

Graves Ophthalmopathy
Myxedema
Decompression
Diplopia
Exophthalmos
Eye Diseases
Graves Disease
Visual Acuity
Thyroid Gland

Keywords

  • Autoimmune thyroid disease
  • Graves’ ophthalmopathy
  • orbital decompression
  • pretibial myxedema
  • thyroid dermopathy

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Orbital decompression in Graves’ ophthalmopathy associated with pretibial myxedema. / Fatourechi, Vahab; Garrity, J. A.; Bartley, G. B.; Bergstralh, E. J.; Gorman, C. A.

In: Journal of endocrinological investigation, Vol. 16, No. 6, 01.01.1993, p. 433-437.

Research output: Contribution to journalArticle

Fatourechi, Vahab ; Garrity, J. A. ; Bartley, G. B. ; Bergstralh, E. J. ; Gorman, C. A. / Orbital decompression in Graves’ ophthalmopathy associated with pretibial myxedema. In: Journal of endocrinological investigation. 1993 ; Vol. 16, No. 6. pp. 433-437.
@article{9ba8b5f98c9e43678a434494b857da1f,
title = "Orbital decompression in Graves’ ophthalmopathy associated with pretibial myxedema",
abstract = "Pretibial myxedema (thyroid dermopathy), an uncommon autoimmune manifestation of Graves’ disease, is almost always associated with significant ophthalmopathy and may be a marker for an unusually prolonged or different course for the ophthalmopathy. However, it is not known if the response to therapy for eye disease is different in patients with pretibial myxedema. We compared the results of orbital decompression in 385 patients without and 52 patients with pretibial myxedema operated on between 1969 and 1989. Preoperative and postoperative characteristics of severe Graves’ ophthalmopathy did not differ in patients with or without pretibial myxedema except for slightly, but not significantly, more proptosis and diplopia in the pretibial myxedema group. In response to a 1989–1990 questionnaire (83{\%} response rate, n=364), 89.1{\%} without (n=319) and 88.9{\%} with (n=45) pretibial myxedema reported satisfactory or acceptable appearance of the eyes. Self-assessment of visual acuity, eye comfort, diplopia, and overall rate of satisfaction with the status of the eyes did not differ between the groups. The presence of pretibial myxedema does not herald an unsatisfactory response to transantral orbital decompression.",
keywords = "Autoimmune thyroid disease, Graves’ ophthalmopathy, orbital decompression, pretibial myxedema, thyroid dermopathy",
author = "Vahab Fatourechi and Garrity, {J. A.} and Bartley, {G. B.} and Bergstralh, {E. J.} and Gorman, {C. A.}",
year = "1993",
month = "1",
day = "1",
doi = "10.1007/BF03348875",
language = "English (US)",
volume = "16",
pages = "433--437",
journal = "Journal of Endocrinological Investigation",
issn = "0391-4097",
publisher = "Editrice Kurtis s.r.l.",
number = "6",

}

TY - JOUR

T1 - Orbital decompression in Graves’ ophthalmopathy associated with pretibial myxedema

AU - Fatourechi, Vahab

AU - Garrity, J. A.

AU - Bartley, G. B.

AU - Bergstralh, E. J.

AU - Gorman, C. A.

PY - 1993/1/1

Y1 - 1993/1/1

N2 - Pretibial myxedema (thyroid dermopathy), an uncommon autoimmune manifestation of Graves’ disease, is almost always associated with significant ophthalmopathy and may be a marker for an unusually prolonged or different course for the ophthalmopathy. However, it is not known if the response to therapy for eye disease is different in patients with pretibial myxedema. We compared the results of orbital decompression in 385 patients without and 52 patients with pretibial myxedema operated on between 1969 and 1989. Preoperative and postoperative characteristics of severe Graves’ ophthalmopathy did not differ in patients with or without pretibial myxedema except for slightly, but not significantly, more proptosis and diplopia in the pretibial myxedema group. In response to a 1989–1990 questionnaire (83% response rate, n=364), 89.1% without (n=319) and 88.9% with (n=45) pretibial myxedema reported satisfactory or acceptable appearance of the eyes. Self-assessment of visual acuity, eye comfort, diplopia, and overall rate of satisfaction with the status of the eyes did not differ between the groups. The presence of pretibial myxedema does not herald an unsatisfactory response to transantral orbital decompression.

AB - Pretibial myxedema (thyroid dermopathy), an uncommon autoimmune manifestation of Graves’ disease, is almost always associated with significant ophthalmopathy and may be a marker for an unusually prolonged or different course for the ophthalmopathy. However, it is not known if the response to therapy for eye disease is different in patients with pretibial myxedema. We compared the results of orbital decompression in 385 patients without and 52 patients with pretibial myxedema operated on between 1969 and 1989. Preoperative and postoperative characteristics of severe Graves’ ophthalmopathy did not differ in patients with or without pretibial myxedema except for slightly, but not significantly, more proptosis and diplopia in the pretibial myxedema group. In response to a 1989–1990 questionnaire (83% response rate, n=364), 89.1% without (n=319) and 88.9% with (n=45) pretibial myxedema reported satisfactory or acceptable appearance of the eyes. Self-assessment of visual acuity, eye comfort, diplopia, and overall rate of satisfaction with the status of the eyes did not differ between the groups. The presence of pretibial myxedema does not herald an unsatisfactory response to transantral orbital decompression.

KW - Autoimmune thyroid disease

KW - Graves’ ophthalmopathy

KW - orbital decompression

KW - pretibial myxedema

KW - thyroid dermopathy

UR - http://www.scopus.com/inward/record.url?scp=0027493888&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027493888&partnerID=8YFLogxK

U2 - 10.1007/BF03348875

DO - 10.1007/BF03348875

M3 - Article

C2 - 8370919

AN - SCOPUS:0027493888

VL - 16

SP - 433

EP - 437

JO - Journal of Endocrinological Investigation

JF - Journal of Endocrinological Investigation

SN - 0391-4097

IS - 6

ER -